Nasolabial Fold Volume Restoration Filler is an application-focused injectable solution designed for the correction of visible nasolabial folds associated with facial volume loss and changes in soft-tissue structure.
Product performance depends strongly on the material system and formulation. For this reason, different injectable biomaterial platforms are offered rather than treating all nasolabial fold fillers as a single product type.
Key Specifications for Procurement
|
Specification |
Procurement Consideration |
|
Active Material |
HA, PLLA, CaHA, PCL, or specified combination |
|
Product Form |
Pre-filled glass/COC syringe, sterile vial, or validated configuration |
|
Fill Volume |
Configured according to specific product model requirements |
|
Concentration |
Material-specific and formulation-dependent |
|
Carrier System |
Applicable to microsphere-based injectable systems |
|
Sterility |
Sterile medical-device terminal sterilization configuration |
|
Packaging |
Primary sterile barrier packaging with secondary protective carton |
|
Storage |
Product-specific validated temperature range |
|
Shelf Life |
Confirmed by product specification and stability testing data |
|
Accessories |
Needle or cannula configuration supplied per product model |
|
Labeling |
Standard medical device or market-specific regulatory labeling |
|
OEM Services |
Private-label, custom volume, and packaging options |
Manufacturing and Quality Control
For injectable medical devices, formulation is only one component of overall product performance. Strict manufacturing controls cover the material selection, raw-material qualification, compounding process, aseptic filling, sterilization, packaging, and finished-product testing.
Manufacturing facilities operate within controlled cleanroom environments, utilizing Class C and Class B areas equipped with Class A zones for critical aseptic processing.
The quality control system incorporates evaluations for:
Raw-material identification and qualification
Formulation homogeneity and consistency
Filling accuracy and container closure integrity
Sterility assurance and endotoxin testing
Physicochemical properties and pH verification
Appearance and particle size distribution
Package integrity and accelerated stability testing
Batch traceability and finished-product release
Material Options for Nasolabial Fold Applications
Hyaluronic Acid (HA): Ready-to-use injectable gel formats utilizing crosslinked or non-crosslinked HA.
Poly-L-Lactic Acid (PLLA): Biodegradable, collagen-stimulating polymer supplied as a sterile lyophilized powder in vials requiring reconstitution.
Calcium Hydroxylapatite (CaHA): Aqueous gel carrier dispersing mineral microspheres for immediate volume and tissue support.
Polycaprolactone (PCL): Microspheres suspended in a specialized gel carrier delivering immediate gel volume alongside progressive biostimulation.
Sterile Packaging and Product Configuration
Packaging must be evaluated as an integral part of the medical-device specification. Available configurations include:
Pre-filled syringes (glass or cyclic olefin copolymer)
Sterile lyophilized glass vials
Hypodermic needles or precision cannulas
Individual blister trays or sterile pouches
Secondary cartons with batch labeling
Product inserts and multilingual IFUs
Market-specific custom labeling and private-label packaging
OEM and Private Label Supply
Product Customization: Material platform, active concentration, fill volume, syringe or vial format, and needle gauge selection.
Packaging Customization: Brand name integration, primary container design, carton artwork, label language, and barcode implementation.
Regulatory Support: Target country compliance evaluation, technical file compilation, labeling requirements, and dossier support.
Commercial Terms: Minimum order quantities (MOQ), sample provisions, pilot batch runs, scalable mass production, and scheduled delivery timelines.
FAQ
Q: What filler is suitable for nasolabial folds?
A: The appropriate filler depends on the intended clinical application, material rheology, injection technique, and approved indication. HA, PLLA, CaHA, and PCL represent distinct product platforms and should not be treated as interchangeable options.
Q: Are products available across HA, PLLA, CaHA, and PCL platforms?
A: Injectable product platforms are maintained across HA, PLLA, CaHA, and PCL. Availability for a specific nasolabial fold application depends on the designated product model and target-market regulatory requirements.
Q: What syringe or vial sizes are available?
A: Available fill volumes and presentation formats depend on the selected product model. Buyers should specify their preferred volume and packaging configuration when requesting a quotation.
Q: Can products be supplied under a private label?
A: OEM and private-label projects can be evaluated based on the selected formulation, packaging requirements, target market, and regulatory pathway.
Q: Can samples be provided prior to bulk purchasing?
A: Sample availability is evaluated according to the selected product, destination country, and project requirements.
Q: What documents are available for distributor evaluation?
A: The documentation package depends on the specific product and market. Product specifications, quality documents, labeling information, and applicable regulatory documentation can be discussed during the formal quotation process.
Hot Tags: nasolabial fold volume restoration filler, China nasolabial fold volume restoration filler manufacturers, suppliers, factory
